Ish Sahai

• Identified acquisition targets in the US within pharmaceutical sub-sectors such as dermatology and neurology • Created and presented to senior management new research methodologies for establishing ‘best practices’ for the department

• Developed pitchbooks, valuation models, comparables and precedent transactions analyses for investment banking teams globally for pitching and execution purposes • Advised the C-suite and Investor Relations divisions of FTSE 100 clients of the UK Citigroup Investment Banking team by preparing periodic financial analysis material • Reduced consumption time by ~30%, halved the error rate and simplified the creation process for a quarterly Board of Director meeting report model for a Healthcare client

• Led 15 analysts and coordinated with teams globally to research inputs on M&A targets/capital raisings such as shareholding patterns , macro-economic data and preliminary industry screenings • Saved $50-100k in license fees by recommending to Senior Management to refrain from purchasing the license to a private company database • Reduced costs of ~$250k/year at the enterprise level by centralising a globally accessible database within Mumbai

Finance, Mergers and Acquisitions, Strategy

Corporate Finance, Derivative Markets, Debt Markets